Successful Treatment of UGT1A1 Deficiency in a Rat Model of Crigler–Najjar Disease by Intravenous Administration of a Liver-Specific Lentiviral Vector

This publication has 41 references indexed in Scilit:

• Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector
  Proceedings of the National Academy of Sciences, 2005
• Treatment of Crigler-Najjar type 1 disease: relevance of early liver transplantation
  Journal of Pediatric Surgery, 2003
• A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler–Najjar syndrome
  Gene Therapy, 2002
• Pediatric liver transplantation in metabolic disease: Clinical decision making
  Pediatric Transplantation, 2002
• Acute Cytokine Response to Systemic Adenoviral Vectors in Mice Is Mediated by Dendritic Cells and Macrophages
  Molecular Therapy, 2001
• Gene Therapy with Bilirubin-UDP-Glucuronosyltransferase in the Gunn Rat Model of Crigler-Najjar Syndrome Type 1
  Human Gene Therapy, 1998
• Long-term reduction of serum bilirubin levels in gunn rats by retroviral gene transfer in vivo
  Liver Transplantation and Surgery, 1998
• Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats.
  Journal of Clinical Investigation, 1996
• Long Term Correction of Bilirubin-UDP-glucuronosyltransferase Deficiency in Gunn Rats by Administration of a Recombinant Adenovirus during the Neonatal Period
  Published by Elsevier ,1996
• Current Therapy for Crigler–Najjar Syndrome Type 1: Report of A World Registry
  Hepatology, 1996